Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?

Nature clinical practice. Gastroenterology & hepatology ·Vol. 1 ·No. 2 ·2004-12-00 ·Pages 72-3

Van Cutsem E

Abstract

暂无摘要

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Van Cutsem Eric

Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium. [email protected]

Article Info

Journal

Nature clinical practice. Gastroenterology & hepatology

Abbr.

Nat Clin Pract Gastroenterol Hepatol

ISSN

1743-4378

DOI

Published

2004-12-00

Pages

72-3

Language

English

Region

England

NLM ID

101226510

Corrections

CommentOn

PMID: 15175435

External Links

Analysis Services